A phase II study of epigenetic therapy with hydralazine and...

Annals of Oncology 2007 / 08 Vol. 18; Iss. 9

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Candelaria, M, Gallardo-Rincon, D, Arce, C, Cetina, L, Aguilar-Ponce, J., Arrieta, O, Gonzalez-Fierro, A, Chavez-Blanco, A, de la Cruz-Hernandez, E, Camargo, M., Trejo-Becerril, C, Perez-Cardenas, E,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdm204
Date:
August, 2007
File:
PDF, 290 KB
english, 2007
Conversion to is in progress
Conversion to is failed